{"Abstract": [0], "Liquid": [1], "biopsies": [2, 265, 271], "are": [3, 123, 266], "increasingly": [4], "used": [5], "for": [6, 52], "cancer": [7, 80, 198], "molecular": [8, 282], "profiling": [9, 82], "that": [10, 245], "enables": [11], "a": [12, 127, 292], "precision": [13, 306], "oncology": [14], "approach.": [15], "Circulating": [16], "extracellular": [17], "nucleic": [18], "acids": [19], "(cell-free": [20], "DNA;": [21], "cfDNA),": [22], "circulating": [23, 28], "tumor": [24, 29, 187], "DNA": [25, 175], "(ctDNA),": [26], "and": [27, 38, 49, 59, 73, 96, 109, 117, 121, 155, 160, 186, 196, 259, 272, 295, 330, 338], "cells": [30], "(CTCs)": [31], "can": [32, 204, 224, 238, 279], "be": [33, 205, 225, 239], "isolated": [34, 58, 104], "from": [35, 176, 308], "the": [36, 208, 216, 235], "blood": [37], "other": [39, 118], "body": [40], "fluids.": [41], "This": [42], "review": [43], "will": [44], "focus": [45, 320], "on": [46, 115, 148, 170, 321], "current": [47], "technologies": [48], "clinical": [50, 130], "applications": [51], "liquid": [53, 150, 289], "biopsies.": [54], "ctDNA/cfDNA": [55, 120], "has": [56], "been": [57, 103], "analyzed": [60], "using": [61, 105, 139], "many": [62], "techniques,": [63], "e.g.,": [64], "droplet": [65], "digital": [66], "polymerase": [67], "chain": [68], "reaction,": [69], "beads,": [70], "emulsion,": [71], "amplification,": [72], "magnetics": [74], "(BEAMing),": [75], "tagged-amplicon": [76], "deep": [77, 84], "sequencing": [78, 85, 90, 94, 99], "(TAm-Seq),": [79], "personalized": [81], "by": [83, 207, 227], "(CAPP-Seq),": [86], "whole": [87, 92, 97], "genome": [88, 98], "bisulfite": [89], "(WGBS-Seq),": [91], "exome": [93], "(WES),": [95], "(WGS).": [100], "CTCs": [101, 122, 237], "have": [102, 301], "biomarker-based": [106], "cell": [107], "capture,": [108], "positive": [110], "or": [111], "negative": [112], "enrichment": [113], "based": [114, 147, 169], "biophysical": [116], "properties.": [119], "being": [124], "exploited": [125], "in": [126, 221, 234, 284, 298], "variety": [128], "of": [129, 211, 230, 255, 305, 313], "applications:": [131], "differentiating": [132], "unique": [133], "immune": [134, 143], "checkpoint": [135, 144], "blockade": [136, 145], "response": [137, 146, 154], "patterns": [138, 337], "serial": [140, 171, 276], "samples;": [141], "predicting": [142, 153], "baseline": [149], "biopsy": [151, 194, 290], "characteristics;": [152], "resistance": [156], "to": [157, 243, 275, 311], "targeted": [158], "therapy": [159], "chemotherapy": [161], "as": [162, 164, 251, 253, 326, 333, 335, 341], "well": [163, 252, 334], "immunotherapy,": [165], "including": [166, 189, 261], "CAR-T": [167], "cells,": [168], "sampling;": [172], "assessing": [173, 180], "shed": [174, 214], "multiple": [177, 303], "metastatic": [178, 315], "sites;": [179], "potentially": [181], "actionable": [182], "alterations;": [183], "analyzing": [184], "prognosis": [185], "burden,": [188], "after": [190], "surgery;": [191], "interrogating": [192], "difficult-to": [193], "tumors;": [195], "detecting": [197], "at": [199], "early": [200, 309], "stages.": [201], "The": [202], "latter": [203], "limited": [206], "small": [209], "amounts": [210], "tumor-derived": [212], "components": [213], "into": [215], "circulation;": [217], "furthermore,": [218], "cfDNA": [219], "assessment": [220], "all": [222], "cancers": [223], "confounded": [226], "clonal": [228], "hematopoeisis": [229], "indeterminate": [231], "potential,": [232], "especially": [233], "elderly.": [236], "technically": [240], "more": [241], "difficult": [242], "isolate": [244], "cfDNA,": [246], "but": [247], "permit": [248], "functional": [249], "assays,": [250], "evaluation": [254], "CTC-derived": [256], "DNA,": [257], "RNA": [258], "proteins,": [260], "single-cell": [262], "analysis.": [263], "Blood": [264], "less": [267], "invasive": [268], "than": [269], "tissue": [270], "hence": [273], "amenable": [274], "collection,": [277], "which": [278], "provide": [280], "critical": [281], "information": [283], "real": [285], "time.": [286], "In": [287], "conclusion,": [288], "is": [291], "powerful": [293], "tool,": [294], "remarkable": [296], "advances": [297], "this": [299], "technology": [300], "impacted": [302], "aspects": [304], "oncology,": [307], "diagnosis": [310], "management": [312], "refractory": [314], "disease.": [316], "Future": [317], "research": [318], "may": [319], "fluids": [322], "beyond": [323], "blood,": [324], "such": [325, 340], "ascites,": [327], "effusions,": [328], "urine,": [329], "cerebrospinal": [331], "fluid,": [332], "methylation": [336], "elements": [339], "exosomes.": [342]}